Semaglutide may help protect against sight loss

• Folks with diabetes may also have the possibly blinding imaginative and prescient situation diabetic retinopathy.
• There’s presently no remedy for diabetic retinopathy.
• A brand new examine has discovered that semaglutide — the lively ingredient present in some GLP-1 drugs prescribed for diabetes and to assist weight reduction — might assist defend the eyes from diabetic retinopathy.

Now, a brand new examine lately printed within the journal Pharmaceutics has discovered that semaglutide — the lively ingredient present in GLP-1 medications like Ozempic for the therapy of sort 2 diabetes and Wegovy for weight reduction — might assist defend the eyes from diabetic retinopathy.

For this lab-based examine, researchers used samples of human retinal endothelial cells that had been handled with completely different concentrations of semaglutide. The cells had been then positioned in an answer with each a excessive glucose degree and excessive degree of oxidative stress — the place there may be an imbalance of antioxidants and free radicals — for twenty-four hours.

Previous research present that oxidative stress plays a role within the formation of diabetic retinopathy.

On the examine’s conclusion, researchers discovered that the retinal cells handled with semaglutide had been twice as prone to survive than cells that had been untreated. Moreover, the handled cells had been discovered to have bigger shops of vitality.

Scientists additionally discovered that three markers of diabetic retinopathy had been decreased within the semaglutide-treated retinal cells. First, the degrees of apoptosis — a type of cell loss of life — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The manufacturing of the free radical mitochondrial superoxide decreased from about 90% to about 10% within the handled retinal cells.

Researchers additionally discovered the quantity of advanced glycation end-products — dangerous compounds that may accumulate in folks with diabetes and are identified to trigger oxidative stress — additionally decreased considerably.

Lastly, scientists reported that the genes concerned within the manufacturing of antioxidants had been extra lively within the semaglutide-treated cells when in comparison with untreated cells. Researchers imagine it is a signal that semaglutide might assist restore injury to the retinal cells.

“Our examine didn’t discover that these medication harmed the retinal cells in any method — as an alternative, it means that GLP1-receptor agonists defend in opposition to diabetic retinopathy, notably within the early phases,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher on the Nationwide and Kapodistrian College in Greece, and lead creator of this examine, stated in a press release.

“Excitingly, these medication might be able to restore injury that has already been achieved and so enhance sight. Medical trials are actually wanted to substantiate these protecting results in sufferers and discover whether or not GLP-1 receptor agonists can sluggish, and even halt, the development of this vision-robbing situation.”
— Ioanna Anastasiou, PhD

Medical Information Right now spoke with Benjamin Bert, MD, a board licensed ophthalmologist at MemorialCare Orange Coast Medical Middle in Fountain Valley, CA, about this examine.

“We’ve identified with any of those drugs which are in a position to cut back the blood glucose ranges in diabetic sufferers, have been proven to be useful long-term for the well being of the microvasculature that exists within the eye,” Bert stated.

“What was distinctive about this examine is that it was displaying that possibly with the semaglutide-type drugs that it could assist to guard from oxidative stress. And so this might probably be a special mechanism that it’s in a position to defend the attention with, in order that’s an interesting speculation and discovering of this specific examine.”
— Benjamin Bert, MD

If semaglutide can assist defend in opposition to oxidative stress, Bert stated it could even be capable to assist with different eye situations.

“Loads of the injury that occurs to our our bodies is from the oxidative stress and free oxygen radicals,” he defined. “We’ve been listening to for a few years about antioxidants and the way essential antioxidants are to the continued well being of our our bodies, and all of the completely different molecules, minerals and vitamins, and issues which you can take that assist as antioxidants.”

“So if the GLP-1 drugs even have any such impression on our mobile operate, then that may be one other good way to have the ability to cut back this specific probably damaging course of,” Bert added.

MNT additionally spoke with Jonathan Gloth, MD, a board certified ophthalmologist and retina specialist, Hackensack Meridian Jersey Shore College Medical Middle and Ocean College Medical Middle in New Jersey, about this analysis.

“I’ve seen diminished diabetic retinopathy in sufferers on GLP-1 receptor agonists; subsequently, the examine outcomes had been per what we’ve been seeing clinically in our diabetic sufferers,” Gloth commented. “It’s crucial that GLP-1 drugs are rigorously studied as they’re so generally prescribed and their utilization has elevated exponentially over the previous few years.”

“I wish to see retina-specific research that evaluate the response to our present retinal therapies — eye injections, laser procedures, and surgical procedure — in these sufferers on GLP-1 receptor agonists vs those that usually are not,” he added.